Cargando…
The co-administration of quetiapine or placebo to cognitive-behavior therapy in treatment refractory depression: A preliminary trial
BACKGROUND: Patients with major depression refractory to repeated pharmacological trials (TRD) may remain symptomatic for many years after their index episode. Augmentation strategies (with lithium or an atypical antipsychotic) or combining an antidepressant with short-term psychotherapy have been u...
Autores principales: | Chaput, Yves, Magnan, Annick, Gendron, Alain |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2553785/ https://www.ncbi.nlm.nih.gov/pubmed/18752690 http://dx.doi.org/10.1186/1471-244X-8-73 |
Ejemplares similares
-
Comparative economic evaluation of quetiapine plus lamotrigine combination vs quetiapine monotherapy (and folic acid vs placebo) in patients with bipolar depression (CEQUEL)
por: Simon, Judit, et al.
Publicado: (2018) -
Quetiapine monotherapy for bipolar depression
por: Thase, Michael E
Publicado: (2008) -
Prolonged, self-administration of ultra-high doses of quetiapine
por: Bavle, Amar, et al.
Publicado: (2013) -
Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials
por: Maneeton, Narong, et al.
Publicado: (2012) -
Quetiapine monotherapy versus placebo in the treatment of children and adolescents with bipolar depression: a systematic review and meta-analysis
por: Maneeton, Benchalak, et al.
Publicado: (2017)